No article text was recorded for this version.
antigenic drift
Version 1 of 169 papers86 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage
- Blog: Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- Blog: Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir
- Blog: A mutagenetic tree hidden Markov model for longitudinal clonal HIV sequence data
- Blog: The technologies and their applications in the prevention and control of main porcine viral diarrhea
- Blog: GIW and InCoB, two premier bioinformatics conferences in Asia with a combined 40 years of history
- Blog: N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody
- Blog: Virus-derived transgenes expressing hairpin RNA give immunity to Tobacco mosaic virus and Cucumber mosaic virus
- Blog: Designing Vaccines that Are Robust to Virus Escape
- Blog: Antivirals against the Chikungunya Virus
- Blog: Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants
- Blog: Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
- Blog: HCoVDB: a comprehensive database encompassing viral genomes, drug targets, and therapeutics of human coronaviruses
- Blog: Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia
- Blog: Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants by Modular, Tetravalent, Bi-paratopic Antibodies
- Blog: Identification of a novel porcine Teschovirus 2 strain as causative agent of encephalomyelitis in suckling piglets with high mortality in China
- Blog: Integrative analysis of viral entry networks and clinical outcomes identifies a protective role for spironolactone in severe COVID-19
- Blog: Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study
- Blog: Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
- Blog: Two TAL effectors of Xanthomonas citri promote pustule formation by directly repressing the expression of GRAS transcription factor in citrus
- Blog: Adversarial AI
- Blog: Modeles mathematiques dynamiques pour la medecine personnalisee
- Blog: SOAPIA: Specificity-Guided Generation of Off-Target-Avoiding Protein Interactions with High Target Affinity
- Blog: The Role of Hydrophobic Nodes in the Dynamics of Class A β-Lactamases
- Blog: REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
- Blog: A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro
- Blog: Subclade B3 and D3 enterovirus D68 among children with severe community-acquired pneumonia in China, 2021 to 2024
- Blog: Small molecule UCM05 inhibits HSV-2 infection via targeting viral glycoproteins and fatty acid synthase with potentiating antiviral immunity
- Blog: Molecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China
- Blog: Predicting drug–Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2
- Blog: Identification of Common Biological Pathways and Drug Targets Across Multiple Respiratory Viruses Based on Human Host Gene Expression Analysis
- Blog: Development and Validation of Novel Cell-free Direct Neutralization Assay for SARS-CoV-2
- Blog: Mutational fitness landscape of human influenza H3N2 neuraminidase
- Blog: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
- Blog: COVID-19 in early 2021: current status and looking forward
- Blog: Response of liver histology to interferon therapy with chronic hepatitis B and C.
- Blog: Targeting protein homeostasis with small molecules as a strategy for the development of pan-coronavirus antiviral therapies
- Blog: Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies
- Blog: Seasonal antigenic prediction of influenza A H3N2 using machine learning
- Blog: A sequence-based machine learning model for predicting antigenic distance for H3N2 influenza virus
- Blog: MAIVeSS: streamlined selection of antigenically matched, high-yield viruses for seasonal influenza vaccine production
- Blog: Allosteric hotspots in the main protease of SARS-CoV-2
- Blog: Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
- Blog: Genotype F Mumps Viruses Continue to Circulate in China, From 1995 to 2019
- Blog: Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
- Blog: Modeling viral coevolution: HIV multi-clonal persistence and competition dynamics
- Blog: Reassortment and genomic analysis of a G9P[8]-E2 rotavirus isolated in China
- Blog: Monovalent, bivalent and biparatopic nanobodies targeting S1 protein of porcine epidemic diarrhea virus efficiently neutralized the virus infectivity
- Blog: SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals
- Blog: Identification of a universal antigen epitope of influenza A virus using peptide microarray
- Blog: Asprellcosides B of Ilex asprella Inhibits Influenza A Virus Infection by Blocking the Hemagglutinin- Mediated Membrane Fusion
- Blog: Phylogenetic analysis of the viral proteins VP4/VP7 of circulating human rotavirus strains in China from 2016 to 2019 and comparison of their antigenic epitopes with those of vaccine strains
- Blog: Host Heterogeneous Ribonucleoprotein K (hnRNP K) as a Potential Target to Suppress Hepatitis B Virus Replication
- Blog: Maximum n-times Coverage for Vaccine Design
- Blog: Dynamics of adaptive immunity against phage in bacterial populations
- Blog: Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo
- Blog: Similarities and Evolutionary Relationships of COVID-19 and Related Viruses
- Blog: Engineering Phage Host-Range and Suppressing Bacterial Resistance Through Phage Tail Fiber Mutagenesis
- Blog: Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007
- Blog: Lysosomal “TRAP”: a neotype modality for clearance of viruses and variants
Showing 60 of 69 papers.
History & citation
Current · Permanent link
- This direction split from Predicting and Countering Viral Immune Escape (94% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_antigenic_drift_fd08b967,
title = {antigenic drift},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/antigenic-drift/rdr_fd08b967bf434ef8892b210f4051e2ee},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_antigenic_drift_fd08b967_v1,
title = {antigenic drift},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/antigenic-drift/rdr_fd08b967bf434ef8892b210f4051e2ee/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}